These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


495 related items for PubMed ID: 22771387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
    Lien SC, Usami S, Chien S, Chiu JJ.
    Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J, Palumbo K, Tomcik M, Zerr P, Dees C, Horn A, Maurer B, Akhmetshina A, Beyer C, Sadowski A, Schneider H, Shiozawa S, Distler O, Schett G, Allanore Y, Distler JH.
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [Abstract] [Full Text] [Related]

  • 4. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
    Palcy S, Bolivar I, Goltzman D.
    J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
    [Abstract] [Full Text] [Related]

  • 5. Role of activator protein-1 on the effect of arginine-glycine-aspartic acid containing peptides on transforming growth factor-beta1 promoter activity.
    Ruiz-Torres MP, Perez-Rivero G, Diez-Marques ML, Griera M, Ortega R, Rodriguez-Puyol M, Rodríguez-Puyol D.
    Int J Biochem Cell Biol; 2007 Dec; 39(1):133-45. PubMed ID: 16978906
    [Abstract] [Full Text] [Related]

  • 6. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S, Pardali E, Tchaikovski V, ten Dijke P, Waltenberger J.
    Cardiovasc Res; 2011 Aug 01; 91(3):510-8. PubMed ID: 21478266
    [Abstract] [Full Text] [Related]

  • 7. Prolidase-dependent regulation of TGF β (corrected) and TGF β receptor expressions in human skin fibroblasts.
    Surazynski A, Miltyk W, Prokop I, Palka J.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):115-9. PubMed ID: 20868675
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k.
    Lechuga CG, Hernández-Nazara ZH, Domínguez Rosales JA, Morris ER, Rincón AR, Rivas-Estilla AM, Esteban-Gamboa A, Rojkind M.
    Am J Physiol Gastrointest Liver Physiol; 2004 Nov 15; 287(5):G974-87. PubMed ID: 15246963
    [Abstract] [Full Text] [Related]

  • 9. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S, Zhuang Y, Shan B, Danchuk S, Luo F, Korfei M, Guenther A, Lasky JA.
    PLoS One; 2017 Nov 15; 12(10):e0186615. PubMed ID: 29045477
    [Abstract] [Full Text] [Related]

  • 10. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
    Leaner VD, Donninger H, Ellis CA, Clark GJ, Birrer MJ.
    Mol Cell Biol; 2005 Apr 15; 25(8):3324-37. PubMed ID: 15798216
    [Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts.
    Eickelberg O, Pansky A, Koehler E, Bihl M, Tamm M, Hildebrand P, Perruchoud AP, Kashgarian M, Roth M.
    FASEB J; 2001 Mar 15; 15(3):797-806. PubMed ID: 11259398
    [Abstract] [Full Text] [Related]

  • 12. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways.
    Tacheau C, Fontaine J, Loy J, Mauviel A, Verrecchia F.
    J Cell Physiol; 2008 Dec 15; 217(3):759-68. PubMed ID: 18668519
    [Abstract] [Full Text] [Related]

  • 13. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A, Cuozzo C, Esposito I, Maggiolini M, Bonofiglio D, Vivacqua A, Garramone M, Weiss C, Bohmann D, Musti AM.
    Oncogene; 2002 Sep 19; 21(42):6434-45. PubMed ID: 12226747
    [Abstract] [Full Text] [Related]

  • 14. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
    McGaha TL, Kodera T, Spiera H, Stan AC, Pines M, Bona CA.
    Arthritis Rheum; 2002 Oct 19; 46(10):2748-61. PubMed ID: 12384935
    [Abstract] [Full Text] [Related]

  • 15. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.
    Shi-Wen X, Rodríguez-Pascual F, Lamas S, Holmes A, Howat S, Pearson JD, Dashwood MR, du Bois RM, Denton CP, Black CM, Abraham DJ, Leask A.
    Mol Cell Biol; 2006 Jul 19; 26(14):5518-27. PubMed ID: 16809784
    [Abstract] [Full Text] [Related]

  • 16. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A, McClure TD, Brekken RA, Motamed K, Murri C, Wang T, Sage EH.
    J Cell Biochem; 2004 Apr 01; 91(5):915-25. PubMed ID: 15034927
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG.
    Oncogene; 2003 Jul 10; 22(28):4314-32. PubMed ID: 12853969
    [Abstract] [Full Text] [Related]

  • 18. Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38.
    Ohsawa M, Koyama T, Nara N, Hirosawa S.
    Thromb Res; 2003 Jul 10; 112(5-6):313-20. PubMed ID: 15041276
    [Abstract] [Full Text] [Related]

  • 19. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.
    Kajanne R, Miettinen P, Mehlem A, Leivonen SK, Birrer M, Foschi M, Kähäri VM, Leppä S.
    J Cell Physiol; 2007 Aug 10; 212(2):489-97. PubMed ID: 17348021
    [Abstract] [Full Text] [Related]

  • 20. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS, Hasson B, Boyer-Boiteau A, El-Khishin A, Shashoua VE.
    J Neurosci Res; 2003 May 01; 72(3):405-16. PubMed ID: 12692907
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.